Association between Antipsychotics-Induced Restless Legs Syndrome and Tyrosine Hydroxylase Gene Polymorphism

키워드

참고문헌 (35)

1. Allen RP, "Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health", Sleep Med, 4, pp.101~119 (2003)
2. Sachdev P, "The present status of akathisia", J Nerv Ment Dis, 179, pp.381~391 (1991)
3. Dressler D, "The syndrome of painful legs and moving toes", Mov Disord, 9, pp.13~21 (1994)
4. Bjorvatn B, "Prevalence, severity and risk factors of restless legs syndrome in the general adult population in two Scandinavian countries", Sleep Med, 6, pp.307~312 (2005)
5. Garcia-Borreguero D, "Epidemiology of restless legs syndrome: the current status", Sleep Med Rev, 10, pp.153~167 (2006)
6. Kim J, "Prevalence of restless legs syndrome and associated factors in the Korean adult population: the Korean Health and Genome Study", Psychiatry Clin Neurosci, 59, pp.350~353 (2005)
7. Korean Sleep Society, "Epidemiology of restless legs syndrome", Restless Legs Syndrome (RLS) Media Conference (2006)
8. Hening WA, "An update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder", Sleep, 27, pp.560~583 (2004)
9. Kaplan PW, "A double-blind, placebo-controlled study of the treatment of periodic limb movements in sleep using carbidopa", levodopa and propoxyphene, 1993, pp.16, 717~723
10. Silber MH, "An algorithm for the management of restless legs syndrome", Mayo Clin Proc, pp.916~922 (2004)
11. Thorpy MJ, "New paradigms in the treatment of restless legs syndrome", Neurology, 64(12), pp.S28~S33 (2005)
12. Chang Ho Yun MD, "Pathophysiology of the Restless Legs Syndrome:dopamine and Iron", J Kor Sleep Soc, 3, pp.22~28 (2006)
13. Kryger MH, "Principles and Practice of sleep medicine" (2005), Elsevier Saunders
14. Kaushik P, "Dynamics of tyrosine hydroxylase mediated regulation of dopamine synthesis", J Comput Neurosci, 22, pp.147~160 (2007)
15. O’Malley KL, "Isolation and characterization of the human tyrosine hydroxylase gene: identification of 5’ alternative splice sites responsible for multiple mRNAs", Biochemistry, 26, pp.6910~6914 (1987)
16. Chitbangonsyn SW, "Physical mapping of autonomic", sympathetic candidate genetic loci for hypertension in the human genome: a somatic cell radiation hybrid library approach, 2003, pp.17, 319~324
17. Lüdecke B, "Frequent sequence variant in the human tyrosine hydroxylase gene", Hum Genet, 95, pp.716~ (1995)
18. Benmoyal-Segal L, "Gene-environment interactions in sporadic Parkinson’s disease", J Neurochem, 97, pp.1740~1755 (2006)
19. Ishiguro H, "Systematic search for variations in the tyrosine hydroxylase gene and their associations with schizophrenia, affective disorders, and alcoholism", Am J Med Genet, 81, pp.388~396 (1998)
20. Desautels A, "Dopaminergic neurotransmission and restless legs syndrome: a genetic association analysis", Neurology, 57, pp.1304~1306 (2001)
21. Kunugi H, "Association study of structural mutations of the tyrosine hydroxylasen gene with schizophrenia and Parkinson’s disease", Am J Med Genet, 81, pp.131~133 (1998)
22. Kang SG, "Characteristics and clinical correlates of restless legs syndrome in schizophrenia", Prog Neuropsychopharmacol Biol Psychiatry, 31, pp.1078~1083 (2007)
23. Kang SG, "Association study between antipsychotics-induced restless legs syndrome and polymorphisms of dopamine D1, D2, D3, and D4 receptor genes in schizophrenia", Neuropsychobiology, 57, pp.49~54 (2008)
24. Walters AS, "Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome", Sleep Med, 4, pp.121~132 (2003)
25. Overall JE, "The Brief Psychiatric Rating Scale", Psychol Rep, 10, pp.799~812 (1962)
26. Heon-Jeong Lee, "No Evidence for Association between Tyrosine Hydroxylase Gene Val81Met Polymorphism and Susceptibility to Tardive Dyskinesia in Schizophrenia", PSYCHIATRY INVESTIGATION, 6(2), pp.108~111 (2009), 대한신경정신의학회
27. Berger K, "Sex and the risk of restless legs syndrome in the general population", Arch Intern M, 164, pp.196~202 (2004)
28. Hogl B, "Restless legs syndrome: a community-based study of prevalence, severity, and risk factors", Neurology, 64, pp.1920~1924 (2005)
29. Kritzer MF, "Ovarian hormones influence the morphology, distribution, and density of tyrosine hydroxylase immunoreactive axons in the dorsolateral prefrontal cortex of adult rhesus monkeys", J Comp Neurol, 395, pp.1~17 (1998)
30. McDermott JL, "Sex differences and effects of estrogen on dopamine and DOPAC release from the striatum of male and female CD-1 mice", Exp Neurol, 125, pp.306~311 (1994)
31. Toney TW, "Antiestrogen action in the medial basal hypothalamus and pituitary of immature female rats: insights concerning relationships among estrogen, dopamine, and prolactin", Endocrinology, 119, pp.2661~2669 (1986)
32. Desautels A, "Evidence for a genetic association between monoamine oxidase A and restless legs syndrome", Neurology, 59, pp.215~219 (2002)
33. Marchese G, "Sub-chronic treatment with classical but not atypical antipsychotics produces morphological changes in rat nigro-striatal dopaminergic neurons directly related to “early onset” vacuous chewing", Eur J Neurosci, 15, pp.1187~1196 (2002)
34. Lerner P, "Haloperidol: effect of long-term treatment on rat striatal dopamine synthesis and turnover", Science, 197, pp.181~183 (1977)
35. Han GR, "A Korean population study of the nine STR loci FGA, VWA, D3S1358, D18S51, D21S11, D8S1179, D7S820, D13S317 and D5S818", Int J Legal Med, 114, pp.41~44 (2000)

관련 논문AI추천